TIANYUAN HEALTH (00557) announced that the group expects to achieve total revenue of approximately HK$8.4 million for the first half of 2025, representing a decrease of approximately 44% year-on-year. The expected decline in total revenue is primarily attributable to the temporary suspension of business operations and renovation at Shanghai Yuyue Weilai Medical Beauty Hospital Limited (a plastic surgery specialty hospital in Shanghai, China, in which the group holds a partial interest) during the first half of 2025, resulting in an expected reduction in the group's medical business revenue of no less than approximately HK$6.2 million to approximately HK$0.5 million (compared to approximately HK$6.7 million in the previous period). Additionally, the group expects to record a net loss of approximately HK$8.4 million for the interim period (compared to approximately HK$9 million in the previous period). Based on currently available relevant information, the board of directors believes that the estimated net loss for the interim period is mainly due to the estimated decrease in total revenue compared to the previous period, which is partially offset by a corresponding reduction in operating costs.